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Air pollution exposure is associated with cardiovascular events
triggered by clot formation. Endothelial activation and initiation of
coagulation are pathophysiological mechanisms that could link in-
haled air pollutants to vascular events. Here we investigated the
underlying mechanisms of increased endothelial cell procoagu-
lant activity following exposure to soluble components of ultrafine
particles (soluble UF). Human coronary artery endothelial cells
(HCAEC) were exposed to soluble UF and assessed for their ability
to trigger procoagulant activity in platelet-free plasma. Exposed
HCAEC triggered earlier thrombin generation and faster fibrin
clot formation, which was abolished by an anti-tissue factor (TF)
antibody, indicating TF-dependent effects. Soluble UF exposure in-
creased TF mRNA expression without compensatory increases in
key anticoagulant proteins. To identify early events that regulate
TF expression, we measured endothelial H2O2 production follow-
ing soluble UF exposure and identified the enzymatic source. Sol-
uble UF exposure increased endothelial H2O2 production, and an-
tioxidants attenuated UF-induced upregulation of TF, linking the
procoagulant responses to reactive oxygen species (ROS) forma-
tion. Chemical inhibitors and RNA silencing showed that NOX-
4, an important endothelial source of H2O2, was involved in UF-
induced upregulation of TF mRNA. These data indicate that sol-
uble UF exposure induces endothelial cell procoagulant activity,
which involves de novo TF synthesis, ROS production, and the
NOX-4 enzyme. These findings provide mechanistic insight into the
adverse cardiovascular effects associated with air pollution expo-
sure.
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Epidemiological studies reveal a strong association between
air pollution exposure and increased cardiovascular (CV) mor-
bidity and mortality (Pope et al., 2004, 2006). Exposure to air
pollution can increase thrombus formation in vivo in humans
(Lucking et al., 2008) and animal models (Nemmar et al., 2003),
and may lead to thrombotic events such as acute myocardial in-
farctions (Nawrot et al., 2011; Peters et al., 2004) and venous
thromboembolism (Baccarelli et al., 2008). One of the major
components of air pollution is particulate matter (PM), which is
categorized based on the diameter of the particles: coarse (10–
2.5 m), fine (2.5–0.1 m), and ultrafine (UF; <0.1 m). The
United States Environmental Protection Agency currently mon-
itors and regulates coarse and fine PM, but increasing evidence
suggests that UF particles, which are not currently regulated, are
particularly important mediators of CV effects of air pollution
(Nel, 2005). Although UF particles comprise only a small por-
tion of ambient PM by mass concentration, they constitute the
majority of particle number and have a large surface area-to-
mass ratio. UF particles can deposit in the alveolar region of the
lung due to their small diameter (Kreyling et al., 2004). These
extremely small particles are not efficiently cleared by alveolar
macrophages (Gonzalez et al., 1996), and they may persist in the
lung, increasing the potential to cause adverse effects. Further-
more, soluble components of UF particles (soluble UF) could
enter the vasculature by traversing the alveolar-capillary barrier
(Wallenborn et al., 2007). These soluble components, which in-
clude transition metals, induce oxidative stress and procoagu-
lant activity in animal and human models (Araujo et al., 2008;
Sorensen et al., 2005); however, the mechanisms behind these
responses have not been delineated.
A causal link between vascular effects of PM exposure and
procoagulant responses is suggested by the finding that soluble
UF exposure increases tissue factor (TF) mRNA expression in
human pulmonary artery endothelial cells (Karoly et al., 2007).
TF is not highly expressed on endothelial cells under normal
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physiological conditions, but surface expression is induced by
various stimuli, including inflammatory cytokines, endotoxin,
and hypoxia (Chu, 2005). Altered expression and activity of TF
is of particular interest because, once activated, this membrane-
bound protein is the primary initiator of the extrinsic coagu-
lation pathway, resulting in thrombin generation and throm-
bus formation. Elevated TF levels are associated with adverse
CV effects including thrombosis and atherosclerosis (Mackman
et al., 2007).
TF expression is redox-regulated, and TF mRNA and protein
levels are modulated by reactive oxygen species (ROS) in vas-
cular cells (Herkert and Gorlach, 2002). Endothelial cells pro-
duce ROS in response to several physiological and pathological
stimuli, including exposure to UF particles (Mo et al., 2009).
One major cellular source of ROS production is the NADPH
oxidase (NOX) family of enzymes (Lassegue et al., 2012). En-
dothelial cells express mainly NOX-2 and NOX-4 isoforms with
variable expression levels between endothelial cell types (Guzik
et al., 2004). Nox enzymes produce basal physiological levels of
ROS, and NOX activity is augmented upon agonist stimulation
producing increased ROS levels that play a role in pathophysi-
ological responses (Lassegue et al., 2012). For example, throm-
bin enhances TF expression and procoagulant activity in vascu-
lar smooth muscle cells (VSMC) by stimulating ROS produc-
tion by NOX (Herkert et al., 2002). Furthermore, NOX-induced
oxidative stress in vascular cells is involved in the pathogenesis
of CV disorders (Madamanchi et al., 2005), potentially through
these procoagulant mechanisms.
The objective of our study was to determine if soluble UF in-
duces procoagulant responses in human endothelial cells and to
define the mechanisms behind these effects. We show here that
endothelial cells exposed to soluble UF induce faster onset of
thrombin generation and fibrin clot formation via TF upregula-
tion, which involves ROS production and the NOX-4 enzyme.
MATERIALS AND METHODS
Reagents and chemicals. Human coronary artery endothe-
lial cells (HCAEC), endothelial growth medium (EGM-2), and
EGM-2 Bullet Kit were obtained from Lonza (Walkersville,
MD). All other chemicals and reagents were from Sigma Chem-
ical Company (St. Louis, MO) unless otherwise stated.
Cell culture. HCAEC were cultured in EGM-2 media supple-
mented with the EGM-2 Bullet Kit. Cells were grown to con-
fluence and used between passages 5–8.
UF particles. UF particles collected from February to May
2007 in Chapel Hill, NC were analyzed for chemical compo-
nents (Table 1) by the Research Triangle Institute (Research Tri-
angle Park, NC) as previously described (Becker et al., 2005).
The water-soluble fraction of UF particles was obtained as pre-
viously described (Karoly et al., 2007).
Calibrated automated thrombography assay. Platelet-free
plasma (PFP) from healthy donors was prepared as previously
described (Machlus et al., 2009). Cellular procoagulant activity
was measured as previously described with alterations (Camp-
bell et al., 2009). Briefly, HCAEC were cultured on 96-well
plates and exposed to soluble UF for 6 h. Following expo-
sure, cells and PFP were incubated with an inhibitory anti-
human TF monoclonal inhibitory antibody or control mouse
IgG for 15 min at 37◦C. PFP with antibodies, MP reagent con-
taining phospholipids (4M; 60% phosphatidylcholine/20%
phosphatidylethanolamine/20% phosphatidylserine; Diagnos-
tica Stago, Parsippany, NJ), and a fluorogenic thrombin sub-
strate (Z-Gly-Gly-Arg-AMC; Diagnostica Stago) were then
added to the cells (Machlus et al., 2009). Reactions were cal-
ibrated against wells containing a thrombin calibrator (2-
macroglobulin/thrombin complex; Diagnostica Stago). Throm-
bin generation was measured using a Fluoroskan Ascent
fluorometer (ThermoLabsystem, Helsinki, Finland). Throm-
binoscope software version 3.0.0.29 (Thrombinoscope BV,
Maastricht, Netherlands) was used to calculate lag time (first
time point after the thrombin concentration exceeds one-sixth
peak height), peak (greatest amount of thrombin generation at
a single point in time), time to peak (time to reach the maxi-
mum peak height), and endogenous thrombin potential (ETP;
total amount of thrombin generated during the test).
Turbidity assay. HCAEC were cultured and exposed to sol-
uble UF as described above and fibrin clot formation measured
as previously described (Gray et al., 2011). Clot formation on-
set (time to reach inflection point before turbidity increase) and
Vmax (slope of the line fitted to maximum rate of turbidity in-
crease) were calculated using Softmax Pro Software version
1.21 (Molecular Devices, Sunnyvale, CA).
Real-time quantitative PCR. Relative gene expression in
HCAEC was obtained using quantitative RT-PCR as previ-
ously described (Karoly et al., 2007). Total RNA was isolated
from HCAEC using an RNeasy kit (Qiagen, Valencia, CA)
as per manufacturer’s protocol. RNA was quantified using
a Nanodrop 1000 Spectrophotometer (Thermo Scientific,
Wilmington, DE). Oligonucleotide primer pairs and fluorescent
probes for -actin (forward, 5′-CCTGGCACCCAGCACAAT-
3′; reverse, 5′-GCCGATCCACACGGAGTACT-3′; probe,
5′-ATCAAGATCATTGCTCCTCCTGAGCGC-3′) and TF
(forward, 5′-TTGGCACGGGTCTTCTCCTA-3′; reverse,
5′-CGAGGTTTGTCTCCAGGTAAGG-3′; and probe, 5′-
AGAACCGGTGCTCTCCACATTCCCTG-3′) were designed
using Primer Express (Applied Biosystems, Foster City, CA)
and obtained from Integrated DNA Technologies (Coralville,
IA). Thrombomodulin, endothelial protein C receptor (EPCR),
tissue factor pathway inhibitor (TFPI), GAPDH, and NOX-4
primer pairs and fluorescent probe sets were obtained as Taq-
man pre-developed assay reagents from Applied Biosystems.
Standard curves generated from a serially diluted standard
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TABLE 1
Components of UF PM (ng/mg) Collected in Chapel Hill, NC from February to May 2007
Component ng/mg Component ng/mg
Aluminum 855.0 Nitrate 44100.0
Arsenic 55.8 Nitrite 579.0
Bromide 1824.0 Selenium 76.5
Chromium 12.3 Silicon 3480.0
Copper 108.0 Sulfur 99300.0
Iron 624.0 Titanium 21.5
Lead 79.5 Vanadium 57.0
Nickel 34.2 Zinc 735.0
pool of cDNA prepared from cultured human endothelial cells
exposed to 100 ng/ml TNF- for 6 h were used to determine the
relative abundance of mRNA levels, which were normalized to
relative abundance of -actin mRNA.
H2O2 measurement. Extracellular H2O2 release was
measured using the Amplex Red reagent (10-acetyl-3,7-
dihydroxyphenoxazine; Invitrogen, Carlsbad, CA) as previ-
ously described (Li et al., 2006). Following analysis, cellular
protein was collected and measured using the Bio-Rad protein
reagent (Bio-Rad, Richmond, CA) as per manufacturer’s
protocol.
Peroxy Green 1 (PG1; kindly provided by Dr Christopher
Chang, University of California-Berkeley), a small-molecule
fluorophore that is more responsive to H2O2 than other ROS
(Miller et al., 2007), was used to measure intracellular H2O2 as
previously described (Cheng et al., 2010).
siRNA transfection. HCAEC were transfected with 90nM
concentration of NOX-4 or scrambled no. 5 siRNA using
siPORT Amine transfection agent (Ambion, Austin, TX) as per
manufacturer’s protocol. Cells were used for experiments 48 h
post-transfection.
Statistical analysis. Statistical analysis was performed using
GraphPad Prism (GraphPad Software, San Diego, CA). A t-test
or one-way ANOVA analysis followed by Bonferroni’s post-
hoc test was used to compare exposed cells with control cells.
A p-value < 0.05 was considered statistically significant.
RESULTS
Soluble UF Cause HCAEC to Promote Earlier Onset of
TF-Dependent Thrombin Generation and Fibrin Clot
Formation
HCAEC were exposed to 10, 50, and 100 g/ml soluble UF.
We found that these doses are non-cytotoxic to the cells (Sup-
plementary fig. 1). Six hours following exposure, cells were as-
sessed for functional coagulation balance using two methods.
We used the calibrated automated thrombography (CAT) assay
to quantify thrombin generation (Figs. 1A–C) and the turbidity
assay to measure the rate of fibrin clot formation (Figs. 1D–F)
in PFP. The CAT assay showed that lag time (Fig. 1B) and time
to peak (Fig. 1C) significantly shortened with increasing doses
of soluble UF, indicating earlier onset of thrombin generation.
Soluble UF exposure did not significantly affect thrombin peak
or ETP (data not shown). In the turbidity assay, HCAEC expo-
sure to soluble UF led to a significant shortening in the onset
time to clot formation (Fig. 1E) and an increase in Vmax (Fig.
1F), indicating earlier onset and faster rate of fibrin clot forma-
tion. These effects on thrombin and fibrin were abolished by
addition of an inhibitory anti-human TF antibody. These data
suggest soluble UF increases endothelial procoagulant activity
via a TF-dependent mechanism.
Soluble UF Increases TF mRNA Expression in HCAEC
To characterize the cause of soluble UF-induced changes in
HCAEC cellular procoagulant activity, we quantified mRNA
expression of key procoagulant and anticoagulant proteins by
RT-PCR following exposure for 6 and 24 h. Exposure to 50 and
100 g/ml of soluble UF led to a significant (p < 0.001) 3.8-
fold and 5.1-fold, respectively, increase of TF mRNA expres-
sion in HCAEC at 6 h, and increased expression was sustained
at 24 h (Fig. 2A). Conversely, we found no significant changes
in thrombomodulin, EPCR, or TFPI following soluble UF ex-
posure (Figs. 2B–D). The upregulation of TF and lack of com-
pensatory changes in the anticoagulant proteins provide a mech-
anistic rationale for the increased cellular procoagulant activity
seen in Figure 1.
Soluble UF-Induced TF Upregulation Involves ROS
To characterize the events initiating increased TF production,
we treated HCAEC with PEG-SOD and PEG-catalase prior to 6
h soluble UF exposure (50 g/ml) and measured TF mRNA ex-
pression. These cell-permeable antioxidants significantly sup-
pressed TF mRNA upregulation by soluble UF by 55% and
36%, respectively (p < 0.001, Fig. 3A). In addition, pretreat-
ment with L-NAME, a nitric oxide synthase inhibitor, did not
attenuate TF mRNA levels following exposure (Fig. 3B). These
data indicate that ROS production is involved in increasing TF
mRNA expression in soluble UF-treated HCAEC.
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FIG. 1. Soluble UF exposure leads to faster onset of TF-dependent thrombin generation and fibrin clot formation. Endothelial cell coagulation balance was
assessed by measuring capacity of HCAEC to induce thrombin generation (A-C) and fibrin clot formation (D-F) in PFP following soluble UF exposure (0, 10,
50, and 100 g/ml). Thrombin parameters lag time (B) and time to peak (C) and the fibrin clot parameters clot formation onset (E) and Vmax (F) were measured.
Graphs are representative of three separate experiments with samples in triplicate. Error bars indicate ± SE. *p < 0.05, **p < 0.01, ***p < 0.001 compared with
control.
Soluble UF Exposure Causes H2O2 Production in HCAEC
To characterize ROS production by endothelial cells, we
measured extracellular and intracellular H2O2 production in sol-
uble UF-treated HCAEC. Using the Amplex Red assay to quan-
tify extracellular H2O2 release, we found an 11.8-fold (p < 0.05)
and 19.7-fold (p < 0.001) increase in extracellular H2O2 levels
following HCAEC exposure to 50 and 100 g/ml soluble UF,
respectively (Fig. 4A). Using the chemical indicator PG1, we
observed a significant and progressive dose-dependent increase
in intracellular H2O2 in cells exposed to 50 (21%, p < 0.05)
and 100 g/ml (32%, p < 0.001) (Fig. 4B). We then visualized
the distribution of intracellular H2O2 production in individual
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FIG. 2. Soluble UF exposure leads to TF upregulation. (A-D) HCAEC were exposed to soluble UF (0, 10, 50, and 100 g/ml) for 6 or 24 h. TF (A),
thrombomodulin (B), EPCR (C), and TFPI (D) mRNA expression were quantified by RT-PCR. Error bars indicate ± SE of n = 3 separate experiments with
samples in triplicate. ***p < 0.001 compared with control.
living cells in real time using confocal microscopy. Soluble UF
(100 g/ml) induced intracellular H2O2 in HCAEC in a diffuse,
cytoplasmic distribution as indicated by increased PG1 fluores-
cence intensity (Fig. 4C). Quantitative analysis of the confo-
cal images indicated a significant increase (p < 0.001) in fold
change over baseline in soluble UF-exposed HCAEC (Fig. 4D).
These data indicate that soluble UF exposure results in immedi-
ate increases in extracellular and intracellular H2O2 production
in HCAEC.
Soluble UF-Induced TF mRNA Expression Involves the NOX-4
Enzyme
To determine the cellular source of soluble UF-induced H2O2
production, we measured extracellular H2O2 production by
HCAEC in the presence of chemical inhibitors targeted towards
the major sources of endothelial ROS production. DPI, a NOX
inhibitor, reduced extracellular H2O2 production in soluble UF-
exposed (50 g/ml) HCAEC by 54% (p < 0.05) (Fig. 5A). Sol-
uble UF-induced extracellular H2O2 levels were not affected by
inhibitors of xanthine oxidases (allopurinol) or mitochondrial
sources (KCN, rotenone), which are other important sources of
endothelial ROS production (data not shown). These data indi-
cate that NOX enzymes are likely the major source of soluble
UF-induced H2O2 production. To determine if NOX enzymes
mediate the increase in TF mRNA, we pretreated HCAEC with
DPI followed by a 6 h soluble UF exposure (50 g/ml). Pre-
treatment with the NOX inhibitor led to a 50% attenuation (p <
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FIG. 3. TF upregulation by soluble UF is ROS dependent. HCAEC were pretreated with 100 U/ml PEG-SOD or PEG-catalase for 1 h (A) or 1mM L-NAME
for 30 min (B) prior to a 6 h exposure to 0 or 50 g/ml soluble UF. TF mRNA expression was quantified by RT-PCR. Error bars indicate ± SE of n = 3 separate
experiments with samples in triplicate. ***p < 0.001 compared with control.
0.01) of the increased TF mRNA levels in exposed cells (Fig.
5B).
Because HCAEC predominately express the NOX-4 isoform
(Yoshida and Tsunawaki, 2008), we more specifically probed
the role of NOX-4 in soluble UF-induced TF mRNA upregula-
tion by transfecting HCAEC with NOX-4 siRNA. Transfection
resulted in 84% knockdown of the target gene mRNA levels as
compared with the scrambled siRNA control after 48 h (Fig.
5C). HCAEC were then transfected with NOX-4 or scrambled
siRNA for 48 h prior to soluble UF exposure for 6 h. Compared
with cells transfected with scrambled siRNA, NOX-4 silenc-
ing significantly (p < 0.001) attenuated soluble UF-induced TF
mRNA upregulation by 56% (Fig. 5D). Together, these data in-
dicate that following soluble UF exposure, ROS and the NOX-4
enzyme are involved in upregulating TF mRNA expression and
endothelial cell-dependent procoagulant activity.
DISCUSSION
There is strong epidemiological evidence supporting a causal
relationship between air pollution exposure and adverse CV
health effects in humans that include clinical events mediated by
thrombosis (Pope et al., 2004, 2006). An important but under-
studied area in this field is the effect of inhaled air pollutants on
vascular cells via soluble components that can translocate into
the vasculature. Here we report that the water-soluble compo-
nents of UF PM induce a procoagulant phenotype in endothelial
cells, supporting earlier onset of thrombin generation and faster
fibrin clot formation, and that these activities are driven by TF
upregulation. We further show that this increase in TF mRNA is
regulated by increased ROS production and the NOX-4 enzyme,
and can be attenuated by treatment of cells with antioxidants or
by inhibiting NOX-4. These novel findings provide mechanistic
insight into the enhanced thrombosis and endothelial dysfunc-
tion that might underlie increased risk for CV morbidity and
mortality associated with air pollution exposure.
Our results add to a growing body of evidence linking air pol-
lution exposure to thrombosis. Recent studies demonstrated hy-
percoagulable effects of air pollution on plasma thrombin gen-
eration in human and animal models (Emmerechts et al., 2012;
Kilinc et al., 2011). Emmerechts et al. demonstrated that el-
evated levels of coarse PM shortened the lag time of throm-
bin generation in microvesicle-rich plasma obtained from dia-
betic individuals exposed to ambient air pollution (Emmerechts
et al., 2012). Our results extend these observations to poten-
tially pathologic effects of PM on cellular procoagulant activ-
ity. Specifically, using the CAT assay, we show that soluble
UF exposure decreased lag time in a dose-dependent manner,
which has been previously shown to be a sensitive reflection of
TF activity (Ollivier et al., 2010). We did not find significant
differences in ETP or peak thrombin; however, this is not sur-
prising because these parameters are typically more associated
with alterations in levels of soluble clotting factors (Machlus
et al., 2009). In vivo, we anticipate that these observed changes
in plasma (Emmerechts et al., 2012; Kilinc et al., 2011) and
cellular procoagulant activity (endothelial cells and possibly
platelets) may be additive or even synergistic, ultimately dys-
regulating multiple thrombin generation parameters simultane-
ously. Moreover, by disrupting endothelial cell function, soluble
UF may also alter expression of endothelial-derived fibrinolytic
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FIG. 4. Soluble UF exposure induces rapid H2O2 generation by HCAEC. (A) HCAEC were exposed to soluble UF (0, 50, and 100 g/ml) and extracellular
H2O2 release was measured using the Amplex Red reagent. (B) HCAEC were exposed to soluble UF (0, 10, 50, and 100 g/ml) for 60 min in the presence of
the H2O2 indicator PG1. Fluorescence was measured with a fluorescent plate reader. Error bars indicate ± SE of n = 3 independent experiments with samples in
triplicate. (C) PG1 fluorescence was detected by confocal microscopy. HCAEC were pre-incubated with PG1 for a baseline measurement, then exposed to 0 or
100 g/ml soluble UF for 30 min. Representative images shown in a pseudo-colored scheme are from baseline and 30 min post-exposure. (D) Quantitative data
from the confocal images were gathered by outlining individual cells and measuring the Relative Fluorrescense Units (RFU) using Nikon NIS-Elements software.
Error bars indicate ± SE of n = 4 independent experiments. *p < 0.05, ***p < 0.001 compared with control.
enzymes (e.g., tissue plasminogen activator), with additive neg-
ative consequences for clot stability. Further study of these in-
triguing possibilities may reveal additional therapeutic targets
for reducing deleterious effects of air pollution on clot quality.
TF expression is generally suppressed in endothelial cells un-
der normal physiological conditions, but is induced by a variety
of stimuli in vitro (Chu, 2005; Karoly et al., 2007) and possi-
bly in vivo (Mackman et al., 2007). Activation of TF from in-
jury or pathological conditions is typically balanced by expres-
sion of anticoagulant proteins such as TFPI (Crawley and Lane,
2008); however, our findings show lack of parallel upregula-
tion of these anticoagulant proteins, resulting in a procoagulant
environment that favors thrombin generation. The TF gene in
endothelial cells contains binding sites for redox-sensitive tran-
scription factors (Herkert and Gorlach, 2002). Accordingly, we
found that in HCAEC, TF mRNA levels following soluble UF
exposure involved the ROS molecules H2O2 and superoxide
rather than NO. This finding supports previous studies showing
attenuated TF mRNA expression in the presence of antioxidants
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FIG. 5. TF mRNA expression following soluble UF exposure requires ROS production and NOX-4. HCAEC pretreated with the NOX inhibitor DPI (50M)
for 30 min followed by exposure to 0 or 50 g/ml soluble UF were used to measure (A) extracellular H2O2 and (B) TF mRNA expression. (C) HCAEC were
transfected with NOX-4 or scramble siRNA for 48 h. mRNA expression of the target gene NOX-4 and non-target gene GAPDH were quantified by RT-PCR. (D)
HCAEC were transfected with NOX-4 or scramble siRNA for 48 h and then exposed to 0 or 50 g/ml soluble UF for 6 h. TF mRNA expression was quantified
by RT-PCR. Error bars indicate ± SE of n = 3 separate experiments with samples in duplicate. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with control.
following exposure to ionizing radiation and inflammatory cy-
tokines (Szotowski et al., 2007).
ROS are implicated in the pathogenesis and progression of
several CV diseases including atherosclerosis, hypertension,
and diabetes (Madamanchi et al., 2005). Additionally, concen-
trations of 7-hydro-8-oxo-2’-deoxyguanosine in lymphocyte
DNA correlated with elevated levels of water-soluble transi-
tion metals in fine PM in humans exposed to ambient air pol-
lution (Sorensen et al., 2005). This measurement has been used
as a biomarker to assess oxidative damage caused by increased
ROS production and suggests air pollution exposure triggers
oxidative stress. We showed that soluble UF components lead
to significant increases in both extracellular and intracellular
endothelial H2O2 production immediately following exposure.
Our data, using the indicator PG1, indicate that ROS are initially
formed intracellularly after soluble UF exposure. This premise
is further supported by confocal microscopy, which showed a
cytoplasmic distribution of H2O2.
NOX is an important source of ROS in vascular cells, and
NOX enzymes have been implicated as a source of oxidative
stress in numerous CV diseases (Lassegue et al., 2012). Al-
though endothelial cells have several major sources of ROS pro-
duction, NOX enzymes induced ROS production in mouse pul-
monary microvascular endothelial cells exposed to whole UF
particles (Mo et al., 2009). Our findings are important because
we show that NOX-4 is the likely source of soluble UF-induced
H2O2 production in human endothelial cells. The intracellular
distribution of NOX-4 is broad and has been shown to be vari-
ably located in the plasma membrane, endoplasmic reticulum,
mitochondria, and nucleus of endothelial cells (Lassegue et al.,
2012). Our data further suggest that NOX-4-derived ROS pro-
duced following soluble UF exposure is cytoplasmic, but can
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escape to the extracellular space. This finding has important im-
plications for paracrine signaling effects by cellular H2O2.
NOX-4 is involved in increasing TF mRNA expression in
HCAEC by soluble UF. Other researchers have shown that ROS
from NOX enzymes induce TF mRNA expression in VSMC af-
ter agonist stimulation by thrombin (Herkert et al., 2002). Our
data extend this finding to endothelial cells after a more subtle
challenge with soluble UF. NOX enzymes are important poten-
tial therapeutic targets for strategies to limit overproduction of
ROS (Schramm et al., 2012) and our data reinforce the concept
that inhibiting these enzymes is a potential approach to combat
adverse CV effects from air pollution exposure.
Our study is novel in the use of primary HCAEC to model
effects of soluble air pollution components. Because these en-
dothelial cells contact blood immediately from the lungs, they
seem likely to receive high levels of any soluble air pollution
components that enter the vasculature. Although it is not known
whether even the smallest PM can translocate from the lung into
the vasculature and cause pathologic effects (Mills et al., 2006;
Nemmar et al., 2002), water-soluble components of the parti-
cles appear in the vasculature following intratracheal instillation
in rats (Wallenborn et al., 2007). Moreover, we previously de-
termined that the insoluble fraction of UF PM does not induce
significant adverse responses in HCAEC (Snow and Carraway,
2010). Our study strongly supports the potential for a pathogenic
role for the water-soluble components of UF particles and im-
plies that in endothelial cell culture systems, soluble UF expo-
sure is more physiologically relevant than whole UF particle ex-
posures. Furthermore, PM can cause cell death in vitro at high
concentrations; however, we confirmed that the doses used in
this study were non-cytotoxic, indicating that the procoagulant
activity following soluble UF exposure was due to endothelial
activation rather than cellular death.
Our study has a few limitations that are common to in
vitro models. First, our study cannot clarify the uncertainty of
whether endothelial TF is expressed in vivo in humans follow-
ing PM exposure, even though TF expression does increase in
vitro and in animals in response to PM (Sun et al., 2008). Fur-
thermore, it has been shown that endothelial TF upregulation
occurs in vascular disease in humans (Shet et al., 2003; Thiru-
vikraman et al., 1996), which is relevant to our postulate that
air pollutants induce endothelial activation. Second, our data
must be interpreted in light of the lack of current evidence for
TF-initiated coagulation as a key early event in adverse CV re-
sponses to air pollution. Several negative studies on the role of
coagulation considered acute exposures to larger air pollution
particles. Yet, a recent study in diabetic individuals did find a
trend towards early increased monocyte and platelet TF expres-
sion and TF+ microparticles following smaller UF particle expo-
sure (Stewart et al., 2010), which suggests effects may differ be-
tween particles depending on size and associated components.
Finally, in vitro studies are limited by the uncertainty in predict-
ing PM component levels experienced by vascular cells after in-
haling known particle concentrations. However, individuals ex-
posed to indoor smoking, fire smoke, or indoor cook stoves can
be transiently exposed to elevated UF particle concentrations on
par with those used to generate soluble fractions for this study
(Afshari et al., 2005; Baxter et al., 2010; Karoly et al., 2007).
Therefore, we estimated levels that would emulate levels of par-
ticle components to which vascular cells could be exposed.
In summary, we have shown that exposure of HCAEC to
soluble UF leads to increased production of intracellular ROS
and activation of the NOX-4 enzyme that regulates TF mRNA.
This activation of the extrinsic pathway results in faster onset
of thrombin generation and fibrin clot formation. These novel
findings support and extend important information regarding
mechanism(s) by which PM exposure results in thrombosis and
adverse CV health effects.
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